Kang S, Park J, Cheng Z, Ye S, Jun S, Kang N
Cells. 2024; 13(21.
PMID: 39513906
PMC: 11544843.
DOI: 10.3390/cells13211799.
Fang Y, Zhang X, Guo Y, Dong Y, Liu W, Hu X
Cell Biochem Biophys. 2023; 81(3):569-576.
PMID: 37572218
DOI: 10.1007/s12013-023-01158-9.
Weng W, Hong J, Owusu-Ansah K, Chen B, Zheng S, Jiang D
Heliyon. 2022; 8(12):e12064.
PMID: 36544829
PMC: 9761725.
DOI: 10.1016/j.heliyon.2022.e12064.
Scutigliani E, Liang Y, IJff M, Rodermond H, Mei X, Korver M
Cancers (Basel). 2022; 14(21).
PMID: 36358669
PMC: 9654690.
DOI: 10.3390/cancers14215250.
Bisht D, Patne K, Rakesh R, Muthuswami R
Front Cell Dev Biol. 2022; 10:870815.
PMID: 35784471
PMC: 9243424.
DOI: 10.3389/fcell.2022.870815.
Nivalenol affects Cyclin B1 level and activates SAC for cell cycle progression in mouse oocyte meiosis.
Lu P, Wang Y, Jiao L, Sun S
Cell Prolif. 2022; 55(9):e13277.
PMID: 35746834
PMC: 9436911.
DOI: 10.1111/cpr.13277.
Sonodynamic therapy induces oxidative stress, DNA damage and apoptosis in glioma cells.
Sun Y, Wang H, Zhang K, Liu J, Wang P, Wang X
RSC Adv. 2022; 8(63):36245-36256.
PMID: 35558463
PMC: 9088833.
DOI: 10.1039/c8ra07099g.
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
Camero S, Vitali G, Pontecorvi P, Ceccarelli S, Anastasiadou E, Cicchetti F
Cells. 2021; 10(11).
PMID: 34831178
PMC: 8616246.
DOI: 10.3390/cells10112956.
Restoration of HDAC1 Enzymatic Activity after Stroke Protects Neurons from Ischemia/Reperfusion Damage and Attenuates Behavioral Deficits in Rats.
Chen J, Wang H, Su Y, Hsu C, Chen J, Liang C
Int J Mol Sci. 2021; 22(19).
PMID: 34638996
PMC: 8508747.
DOI: 10.3390/ijms221910654.
The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells.
Mohiuddin M, Kasahara K
Cancer Genomics Proteomics. 2021; 18(5):661-673.
PMID: 34479918
PMC: 8441760.
DOI: 10.21873/cgp.20288.
HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis.
Chen J, Wang H, Hsu C, Su Y, Chen J, Liang C
Sci Rep. 2021; 11(1):16354.
PMID: 34381129
PMC: 8357973.
DOI: 10.1038/s41598-021-95837-3.
Catalysis-dependent and redundant roles of Dma1 and Dma2 in maintenance of genome stability in Saccharomyces cerevisiae.
Yoblinski A, Chung S, Robinson S, Forester K, Strahl B, Dronamraju R
J Biol Chem. 2021; 296:100721.
PMID: 33933452
PMC: 8165551.
DOI: 10.1016/j.jbc.2021.100721.
The Dark Side of UV-Induced DNA Lesion Repair.
Strzalka W, Zglobicki P, Kowalska E, Bazant A, Dziga D, Banas A
Genes (Basel). 2020; 11(12).
PMID: 33276692
PMC: 7761550.
DOI: 10.3390/genes11121450.
Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells.
Song Y, Park S, Wu Z, Liu K, Seo Y
J Enzyme Inhib Med Chem. 2020; 35(1):1069-1079.
PMID: 32314611
PMC: 7191901.
DOI: 10.1080/14756366.2020.1754812.
The Role of Noncoding RNAs in Double-Strand Break Repair.
Durut N, Mittelsten Scheid O
Front Plant Sci. 2019; 10:1155.
PMID: 31611891
PMC: 6776598.
DOI: 10.3389/fpls.2019.01155.
Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging.
Flex E, Martinelli S, Van Dijck A, Ciolfi A, Cecchetti S, Coluzzi E
Am J Hum Genet. 2019; 105(3):493-508.
PMID: 31447100
PMC: 6731364.
DOI: 10.1016/j.ajhg.2019.07.007.
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, and .
Khan A, LaCava S, Mehta M, Schiff D, Thandoni A, Jhawar S
Oncotarget. 2019; 10(29):2824-2834.
PMID: 31073373
PMC: 6497458.
DOI: 10.18632/oncotarget.26854.
BRG1 Promotes chromatin remodeling around DNA damage sites.
Qi W, Chen H, Lu C, Bu Q, Wang X, Han L
Anim Cells Syst (Seoul). 2018; 22(6):360-367.
PMID: 30533258
PMC: 6282460.
DOI: 10.1080/19768354.2018.1525429.
Single-cell epigenetics - Chromatin modification atlas unveiled by mass cytometry.
Cheung P, Vallania F, Dvorak M, Chang S, Schaffert S, Donato M
Clin Immunol. 2018; 196:40-48.
PMID: 29960011
PMC: 6422338.
DOI: 10.1016/j.clim.2018.06.009.
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells.
Khan A, Misenko S, Thandoni A, Schiff D, Jhawar S, Bunting S
Oncotarget. 2018; 9(40):25833-25841.
PMID: 29899825
PMC: 5995231.
DOI: 10.18632/oncotarget.25383.